1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Expression and Purification Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Escherichia Coli
1.2.3 Mammalian Cell
1.2.4 Yeast
1.2.5 Other
1.3 Market by Application
1.3.1 Global Recombinant Protein Expression and Purification Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical and Biopharmaceutical Company
1.3.3 Research Laboratory
1.3.4 Hospital
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Recombinant Protein Expression and Purification Market Perspective (2017-2028)
2.2 Recombinant Protein Expression and Purification Growth Trends by Region
2.2.1 Recombinant Protein Expression and Purification Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Recombinant Protein Expression and Purification Historic Market Size by Region (2017-2022)
2.2.3 Recombinant Protein Expression and Purification Forecasted Market Size by Region (2023-2028)
2.3 Recombinant Protein Expression and Purification Market Dynamics
2.3.1 Recombinant Protein Expression and Purification Industry Trends
2.3.2 Recombinant Protein Expression and Purification Market Drivers
2.3.3 Recombinant Protein Expression and Purification Market Challenges
2.3.4 Recombinant Protein Expression and Purification Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Expression and Purification Players by Revenue
3.1.1 Global Top Recombinant Protein Expression and Purification Players by Revenue (2017-2022)
3.1.2 Global Recombinant Protein Expression and Purification Revenue Market Share by Players (2017-2022)
3.2 Global Recombinant Protein Expression and Purification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Protein Expression and Purification Revenue
3.4 Global Recombinant Protein Expression and Purification Market Concentration Ratio
3.4.1 Global Recombinant Protein Expression and Purification Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Expression and Purification Revenue in 2021
3.5 Recombinant Protein Expression and Purification Key Players Head office and Area Served
3.6 Key Players Recombinant Protein Expression and Purification Product Solution and Service
3.7 Date of Enter into Recombinant Protein Expression and Purification Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Recombinant Protein Expression and Purification Breakdown Data by Type
4.1 Global Recombinant Protein Expression and Purification Historic Market Size by Type (2017-2022)
4.2 Global Recombinant Protein Expression and Purification Forecasted Market Size by Type (2023-2028) 5 Recombinant Protein Expression and Purification Breakdown Data by Application
5.1 Global Recombinant Protein Expression and Purification Historic Market Size by Application (2017-2022)
5.2 Global Recombinant Protein Expression and Purification Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Recombinant Protein Expression and Purification Market Size (2017-2028)
6.2 North America Recombinant Protein Expression and Purification Market Size by Country (2017-2022)
6.3 North America Recombinant Protein Expression and Purification Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Recombinant Protein Expression and Purification Market Size (2017-2028)
7.2 Europe Recombinant Protein Expression and Purification Market Size by Country (2017-2022)
7.3 Europe Recombinant Protein Expression and Purification Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Expression and Purification Market Size (2017-2028)
8.2 Asia-Pacific Recombinant Protein Expression and Purification Market Size by Country (2017-2022)
8.3 Asia-Pacific Recombinant Protein Expression and Purification Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Recombinant Protein Expression and Purification Market Size (2017-2028)
9.2 Latin America Recombinant Protein Expression and Purification Market Size by Country (2017-2022)
9.3 Latin America Recombinant Protein Expression and Purification Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Expression and Purification Market Size (2017-2028)
10.2 Middle East & Africa Recombinant Protein Expression and Purification Market Size by Country (2017-2022)
10.3 Middle East & Africa Recombinant Protein Expression and Purification Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 OriGene Technologies
11.1.1 OriGene Technologies Company Detail
11.1.2 OriGene Technologies Business Overview
11.1.3 OriGene Technologies Recombinant Protein Expression and Purification Introduction
11.1.4 OriGene Technologies Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.1.5 OriGene Technologies Recent Development
11.2 GenScript
11.2.1 GenScript Company Detail
11.2.2 GenScript Business Overview
11.2.3 GenScript Recombinant Protein Expression and Purification Introduction
11.2.4 GenScript Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.2.5 GenScript Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Detail
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Recombinant Protein Expression and Purification Introduction
11.3.4 Creative Biolabs Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.3.5 Creative Biolabs Recent Development
11.4 ProMab Biotechnologies
11.4.1 ProMab Biotechnologies Company Detail
11.4.2 ProMab Biotechnologies Business Overview
11.4.3 ProMab Biotechnologies Recombinant Protein Expression and Purification Introduction
11.4.4 ProMab Biotechnologies Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.4.5 ProMab Biotechnologies Recent Development
11.5 Sino Biological Inc.
11.5.1 Sino Biological Inc. Company Detail
11.5.2 Sino Biological Inc. Business Overview
11.5.3 Sino Biological Inc. Recombinant Protein Expression and Purification Introduction
11.5.4 Sino Biological Inc. Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.5.5 Sino Biological Inc. Recent Development
11.6 WuXi Biologics.
11.6.1 WuXi Biologics. Company Detail
11.6.2 WuXi Biologics. Business Overview
11.6.3 WuXi Biologics. Recombinant Protein Expression and Purification Introduction
11.6.4 WuXi Biologics. Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.6.5 WuXi Biologics. Recent Development
11.7 Biomatik
11.7.1 Biomatik Company Detail
11.7.2 Biomatik Business Overview
11.7.3 Biomatik Recombinant Protein Expression and Purification Introduction
11.7.4 Biomatik Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.7.5 Biomatik Recent Development
11.8 Biointron
11.8.1 Biointron Company Detail
11.8.2 Biointron Business Overview
11.8.3 Biointron Recombinant Protein Expression and Purification Introduction
11.8.4 Biointron Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.8.5 Biointron Recent Development
11.9 Novus Biologicals
11.9.1 Novus Biologicals Company Detail
11.9.2 Novus Biologicals Business Overview
11.9.3 Novus Biologicals Recombinant Protein Expression and Purification Introduction
11.9.4 Novus Biologicals Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.9.5 Novus Biologicals Recent Development
11.10 BiologicsCorp
11.10.1 BiologicsCorp Company Detail
11.10.2 BiologicsCorp Business Overview
11.10.3 BiologicsCorp Recombinant Protein Expression and Purification Introduction
11.10.4 BiologicsCorp Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.10.5 BiologicsCorp Recent Development
11.11 Eurofins Discovery
11.11.1 Eurofins Discovery Company Detail
11.11.2 Eurofins Discovery Business Overview
11.11.3 Eurofins Discovery Recombinant Protein Expression and Purification Introduction
11.11.4 Eurofins Discovery Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.11.5 Eurofins Discovery Recent Development
11.12 EUPROTEIN
11.12.1 EUPROTEIN Company Detail
11.12.2 EUPROTEIN Business Overview
11.12.3 EUPROTEIN Recombinant Protein Expression and Purification Introduction
11.12.4 EUPROTEIN Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.12.5 EUPROTEIN Recent Development
11.13 Thermo Fisher
11.13.1 Thermo Fisher Company Detail
11.13.2 Thermo Fisher Business Overview
11.13.3 Thermo Fisher Recombinant Protein Expression and Purification Introduction
11.13.4 Thermo Fisher Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.13.5 Thermo Fisher Recent Development
11.14 Rockland
11.14.1 Rockland Company Detail
11.14.2 Rockland Business Overview
11.14.3 Rockland Recombinant Protein Expression and Purification Introduction
11.14.4 Rockland Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.14.5 Rockland Recent Development
11.15 Creative BioMart
11.15.1 Creative BioMart Company Detail
11.15.2 Creative BioMart Business Overview
11.15.3 Creative BioMart Recombinant Protein Expression and Purification Introduction
11.15.4 Creative BioMart Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.15.5 Creative BioMart Recent Development
11.16 GeNext Genomics
11.16.1 GeNext Genomics Company Detail
11.16.2 GeNext Genomics Business Overview
11.16.3 GeNext Genomics Recombinant Protein Expression and Purification Introduction
11.16.4 GeNext Genomics Revenue in Recombinant Protein Expression and Purification Business (2017-2022)
11.16.5 GeNext Genomics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
